Advancements in diagnosis, management & treatment have significantly improved diabetes care, offering more precise and individualized approaches. Early diagnosis relies on fasting glucose, HbA1c levels, and continuous glucose monitoring, enabling timely intervention. Management strategies incorporate a combination of pharmacological treatments, lifestyle modifications, and emerging digital health technologies. While metformin remains a first-line therapy, newer agents such as GLP-1 receptor agonists and SGLT2 inhibitors provide cardiovascular and renal benefits beyond glycemic control. Insulin therapy continues to evolve, with ultra-long-acting formulations improving adherence. Personalized treatment plans integrating dietary counseling, physical activity, and behavioral support ensure optimal outcomes, while telemedicine and wearable devices enhance patient monitoring and engagement in diabetes self-care.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti